Neurocrine Biosciences, Inc. (NBIX): Price and Financial Metrics
Neurocrine Biosciences, Inc. (NBIX)
Today's Latest Price: $116.91 USD
Updated Jan 22 4:00pm
Add NBIX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
NBIX Stock Summary
- With a price/earnings ratio of 115.04, Neurocrine Biosciences Inc P/E ratio is greater than that of about 91.48% of stocks in our set with positive earnings.
- In terms of twelve month growth in earnings before interest and taxes, Neurocrine Biosciences Inc is reporting a growth rate of 134.56%; that's higher than 90.27% of US stocks.
- As for revenue growth, note that NBIX's revenue has grown 54.24% over the past 12 months; that beats the revenue growth of 90.39% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Neurocrine Biosciences Inc, a group of peers worth examining would be IPGP, NOVT, CGNX, PTC, and MRCY.
- Visit NBIX's SEC page to see the company's official filings. To visit the company's web site, go to www.neurocrine.com.
NBIX Stock Price Chart Interactive Chart >
NBIX Price/Volume Stats
| Current price | $116.91 | 52-week high | $136.26 |
| Prev. close | $115.00 | 52-week low | $72.14 |
| Day low | $114.08 | Volume | 647,900 |
| Day high | $117.71 | Avg. volume | 1,001,600 |
| 50-day MA | $97.90 | Dividend yield | N/A |
| 200-day MA | $108.04 | Market Cap | 10.92B |
Neurocrine Biosciences, Inc. (NBIX) Company Bio
Neurocrine Biosciences discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company was founded in 1992 and is based in San Diego, California.
Loading social stream, please wait...